The GLP-1 receptor is expressed in the CNS in neurons and reactive glia and the effects of liraglutide include inhibition of inflammation and improvement in synaptic connectivity in multiple in vivo models of AD and PD1. Here, GLP1R is linked to Alzheimer disease.